Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.85 is 24% below its 5-year average of 7.68, near the low end of its 5-year range (5.11–20.88).
As of the fiscal period ended Tuesday, June 30, 2026. 4.06% below its 12-month average of 6.10.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.85.
QUICK RATIO (ACID-TEST)
5.85
QUICK RATIO (ACID-TEST) AVG TTM
6.10
QUICK RATIO (ACID-TEST) AVG 3Y
7.13
QUICK RATIO (ACID-TEST) AVG 5Y
7.68
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.06%
CURRENT VS 3Y AVG
-18.01%
CURRENT VS 5Y AVG
-23.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
+95.62%
vs the sector median at left
Castle Biosciences, Inc.
Market Cap
$1.09B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.10
3Y Avg
7.13
5Y Avg
7.68
Market Cap
$1.11B
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.54
3Y Avg
2.42
5Y Avg
2.25
Market Cap
$1.10B
Quick Ratio (Acid-Test)
8.13
TTM Avg
7.23
3Y Avg
6.69
5Y Avg
8.24
Market Cap
$1.10B
Quick Ratio (Acid-Test)
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.14B
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.01
3Y Avg
3.15
5Y Avg
3.64
Market Cap
$1.16B
Quick Ratio (Acid-Test)
1.38
TTM Avg
3.96
3Y Avg
6.78
5Y Avg
9.79
Market Cap
$1.17B
Quick Ratio (Acid-Test)
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.04B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$1.03B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.09B | 5.85 | 6.10 | 7.13 | 7.68 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 1.71 | 2.54 | 2.42 | 2.25 |
| IRadimed Corporation (IRMD)vs › | $1.10B | 8.13 | 7.23 | 6.69 | 8.24 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.10B | 11.59 | 21.25 | 14.51 | 14.51 |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 2.08 | 2.01 | 3.15 | 3.64 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 1.38 | 3.96 | 6.78 | 9.79 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | 33.10 | 10.19 | 10.19 | 10.19 |
| Teladoc Health, Inc. (TDOC)vs › | $1.04B | 0.81 | 2.16 | 2.71 | 2.89 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 1.44 | 1.13 | 1.10 | 1.10 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.16B | 19.73 | 13.53 | 9.78 | 15.63 |
Quick Ratio
5.85
Excludes inventory
Current Ratio
6.04
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.85 |
| 2026-03-31 | 6.53 |
| 2025-12-31 | 5.11 |
| 2025-09-30 | 6.31 |
| 2025-06-30 | 6.69 |
| 2025-03-31 | 9.19 |
| 2024-12-31 | 7.13 |
| 2024-09-30 | 7.64 |
| 2024-06-30 | 7.92 |
| 2024-03-31 | 9.02 |
| 2023-12-31 | 6.04 |
| 2023-09-30 | 7.54 |
| 2023-06-30 | 7.80 |
| 2023-03-31 | 8.84 |
| 2022-12-31 | 7.98 |
| 2022-09-30 | 9.25 |
| 2022-06-30 | 10.96 |
| 2022-03-31 | 8.45 |
| 2021-12-31 | 14.13 |
| 2021-09-30 | 18.44 |
| 2021-06-30 | 20.88 |
| 2021-03-31 | 24.14 |
| 2020-12-31 | 20.47 |
| 2020-09-30 | 6.59 |
| 2020-06-30 | 6.87 |
| 2020-03-31 | 7.56 |
| 2019-12-31 | 7.55 |
| 2019-09-30 | 11.80 |
| 2019-06-30 | 2.38 |
| 2019-03-31 | 4.97 |
| 2018-12-31 | 2.56 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
